While reporting financial results for the second quarter on Tuesday, Elanco Animal Health Inc. (ELAN) narrowed its adjusted earnings and revenue guidance range for the full-year 2019. This primarily reflects the increased headwind from African Swine Fever and anticipated supply disruption of certain injectable cattle products offset by the positive impact from business development actions.
from RTT - Earnings https://ift.tt/2TzjTQ0
via IFTTT
No comments:
Post a Comment